Target intelligence / Profile preview

RNA, U6 small nuclear 296, pseudogene (RNU6-296P)

Target
RNU6-296P
Molecular classification
Other (pseudogene)
01

Overview

RNA, U6 small nuclear 296, pseudogene (RNU6-296P) is classified as a **pseudogene** derived from U6 small nuclear RNA (snRNA) sequences[1][6]. U6 snRNAs are essential components of the spliceosome, the cellular machinery responsible for removal of introns from pre-mRNA during mRNA splicing[3][5]. However, RNU6-296P lacks protein-coding capability and does not produce a functional RNA product; it bears sequence similarity to authentic U6 snRNA genes but contains structural differences such as direct sequence repeats, reflecting its origin as a nonfunctional genomic copy[2]. There are many U6-derived pseudogenes in the human genome, which are considered "genomic fossils" without canonical regulatory or enzymatic activity[5][2]. No evidence exists for a physiological, pathological, or therapeutic role of RNU6-296P. **Key Points:** - RNU6-296P is a **pseudogene** and not an active molecular target, enzyme, transporter, or receptor. - It is not implicated in biological processes, disease roles, or therapeutic mechanisms. - No drugs, disease associations, mechanisms of action, biomarkers, or safety concerns are reported for this pseudogene. - Its sequence reflects evolutionary remnants of the essential U6 snRNA gene, central in spliceosome function, but **RNU6-296P itself is nonfunctional**[2][6].

Other names
RNU6-296PRNA, U6 small nuclear 296 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 296, pseudogene (RNU6-296P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 296, pseudogene (RNU6-296P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call